Sort
48,018 grants matching “immunotherapy”
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
$507,282Jordan Scott Orange · Columbia University Health Sciences · R37 · FY2024 · AI
Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
$507,197Fabiana Perna · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2025 · CA
Allergen T cell epitopes and phenotypes in peanut allergy
$507,183William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2020 · AI
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
$507,168Victor H. Engelhard · University Of Virginia · R01 · FY2023 · CA
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
$507,168Victor H. Engelhard · University Of Virginia · R01 · FY2022 · CA
Early Detection of Cerebral Amyloid Angiopathy
$507,128Steven M Greenberg · Massachusetts General Hospital · R01 · FY2010 · NS
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$507,066Justin M Balko · Vanderbilt University Medical Center · R01 · FY2022 · CA
Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients
$507,016Imon Banerjee · Mayo Clinic Arizona · U01 · FY2024 · CA
Functional Immunomics Core
$507,000Bing Li · University Of Louisville · P20 · FY2020 · GM
Engineering Metal Ion-Immunity Crosstalk for Metalloimmunotherapy
$507,000Xiaoqi Kevin Sun · Icahn School Of Medicine At Mount Sinai · DP2 · FY2025 · AI
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
$506,986Peixuan Guo · Ohio State University · U01 · FY2020 · CA
Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC)on Immunotherapy
$506,985Despina Kontos · Columbia University Health Sciences · R01 · FY2025 · CA
Core C: Correlative Sciences PDCS/TCSL
$506,950Jan J Melenhorst · University Of Pennsylvania · P01 · FY2019 · CA
Core C: Correlative Sciences PDCS/TCSL
$506,950Simon F Lacey · University Of Pennsylvania · P01 · FY2021 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$506,843Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · CA
Methamphetamine and HIV: Defective immunity with CD8 T cell dysfunction
$506,786Howard S. Fox · University Of Nebraska Medical Center · R01 · FY2015 · DA
Identifying and targeting neoantigens in aggressive salivary carcinomas
$506,762Luc Gordon Trang Morris · Sloan-Kettering Inst Can Research · R01 · FY2021 · DE
Metabolic Control of Immune Suppression in Gliomas
$506,747Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2015 · NS
Therapeutically harnessing anti-viral resident memory T cells in solid tumors
$506,676Pamela Rosato · Dartmouth College · R01 · FY2023 · CA
Acute Kidney Injury and Double Negative T Cells
$506,667Abdel Hamad · Johns Hopkins University · R01 · FY2021 · DK
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$506,606Jung Soo Suk · Johns Hopkins University · R01 · FY2021 · NS
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$506,599Anant Madabhushi · Emory University · R01 · FY2024 · CA
Immune Regulation of Neuronal Injury and Repair
$506,576Kathryn Jane Jones · Indiana University Indianapolis · R01 · FY2014 · NS
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$506,551Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Basic Medical Research Training in Oncology
$506,513Olufunmilayo I Olopade · University Of Chicago · T32 · FY2021 · CA